2022, Number 2
Endogenous antioxidants, clinical laboratory variables and immunosuppressants in recipients of functioning renal transplants
Language: Spanish
References: 25
Page: 241-251
PDF size: 453.22 Kb.
ABSTRACT
Introduction: the deleterious effects of uremia, temporary renal replacement therapies, immunosuppressive medication and the overdimensioned action of oxidative stress in renal transplant recipients, lead to accelerated post-graft atherosclerosis. Objective: to relate the expression of oxidative stress indicators with clinical laboratory and immunosuppressive parameters in patients with functioning renal transplantation. Methods: A total of 127 samples were analyzed: 54 from transplanted patients attended in the Nephrology Service and 73 supposedly healthy individuals taken as control. It was determined the activity of antioxidant enzymes; superoxide dismutase, catalase, as well as glutathione concentrations by spectrophotometric techniques. Clinical laboratory variables included; hemoglobin, creatinine, uric acid and albumin. Immunosuppressive therapies were based on combinations of prednisone, mycophelonate mofetil®, tacrolimus® and cyclosporine A®. The statistical program SPSS was used for comparisons and correlations, taking into account a significance level of 95%. Results: It was evidenced a significant decrease of the three oxidative stress indicators in transplanted patients. No significant differences were found when comparing clinical laboratory variables with oxidative stress indicators in subgroups of patients. There were also no differences between combinations of inmunosuppressants, creatinine levels and endogenous antioxidants. Conclusions: Affectation of endogenous antioxidant system in patients with renal transplant is confirmed, independently of the use of immunosuppressors.REFERENCES
Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D, et al. US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis [Internet]. 2020 [citado 21/12/2021];75(1):A6-A7. Disponible en: https://www.ajkd.org/article/S0272-6386(19)31009-1/fulltext. https://doi.org/10.1053/j.ajkd.2019.09.003
Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis [Internet]. 2014 [citado 21/12/2021];63(5):713-735. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24647050/. https://doi.org/10.1053/j.ajkd.2014.01.416
Leffondre K, Boucquemont J, Tripepi G, Stel VS, Heinze G, Dunkler D. Analysis of risk factors associated with renal function trajectory over time: a comparison of different statistical approaches. Nephrol Dial Transplant [Internet]. 2015 [citado 21/12/2021];30(8):1237-1243. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25326471/. https://doi.org/10.1093/ndt/gfu320
Di Lullo L, Bellasi A, Barbera V, Russo D, Russo L, Di Iorio B, et al. Pathophysiology of the cardio-renal syndromes types 1-5: an uptodate. Indian Heart J [Internet]. 2017 [citado 21/12/2021];69(2):255-65. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415026/. https://doi.org/10.1016/j.ihj.2017.01.005
Jiménez Corona AE, Hernández Hernández G, Martínez Santos LR. Nuevos biomarcadores usados en el diagnóstico del dańo renal en condiciones de estrés oxidativo. Cienc Huasteca Bol Cient Esc Superior Huejutla [Internet]. 2019 [citado 21/12/2021];7(14):1-8. Disponible en: https://repository.uaeh.edu.mx/revistas/index.php/huejutla/article/download/4409/6361/. https://doi.org/10.29057/esh.v7i14.4409
Rangaswami J, Bangalore S, Kaplan B, Birdwell KA, Wiseman AC, McCullough PA, et al. Cardiovascular disease care fragmentation in kidney transplantation: a call for action. Kidney Int [Internet]. 2019 [citado 21/12/2021];96(3):568-571. Disponible en: https://www.kidneyinternational-online.org/article/S0085-2538(19)30586-1/fulltext. https://doi.org/10.1016/j.kint.2019.04.042
Asociación Médica Mundial. Declaración de Helsinki de la AMM-Principios éticos para las investigaciones médicas en seres humanos [Internet]. Ferney Voltaire: AMM; 2017 [citado 21/12/2021]. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/
Sotomayor CG, Cortés I, Gormaz JG, Vera S, Libuy M, Valls N, et al. Role of oxidative stress in renal Transplantation: bases for a n-3 PUFA strategy against delayed graft function. Curr Med Chem [Internet]. 2017 [citado 21/12/2021];24(14):1469-1485. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28245764/. https://doi.org/10.2174/0929867324666170227115435
Tennankore K, Kim SJ, Alwayn IP, Kiberd BA. Prolonged warm ischemia time is associated with graft failure and mortality after kidney transplantation. Kidney Int [Internet]. 2016 [citado 21/12/2021];89(3):648-658. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26880458/. https://doi.org/10.1016/j.kint.2015.09.002
Crawford A, Fassett RG, Coombes JS, Kunde DA, Ahuja KDK, Robertson IK, et al. Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and progression of chronic kidney disease. Nephrol Dial Transplant [Internet]. 2011 [citado 21/12/2021];26(9):2806-2813. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21325350/. https://doi.org/10.1093/ndt/gfq828
Tabriziani H, Lipkowitz MS, Vuong N. Chronic kidney disease, kidney transplantation and oxidative stress: a new look to successful kidney transplantation. Clin Kidney J [Internet]. 2018 [citado 21/12/2021];11(1):130-135. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798135/. https://doi.org/10.1093/ckj/sfx091
Vostálová J, Galandáková A, Rajnochová Svobodová A, Orolinová E, Kajabová M, Schneiderka P, et al. Time-course evaluation of oxidative stress-related biomarkers after renal transplantation. Ren Fail [Internet]. 2012 [citado 21/12/2021];34(4):413-419. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22263958/. https://doi.org/10.3109/0886022x.2011.649658
Akbasli AC, Keven K, Erbay B, Nebioglu S. Changes in oxidative stress in renal graft patients receiving calcineurin inhibitors: cyclosporine versus tacrolimus. Exp Clin Transplant [Internet]. 2012 [citado 21/12/2021];10(5):439-445. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22817282/. https://doi.org/10.6002/ect.2011.0172
Cvetkovic T, Velickovic-Radovanovic R, Stojanovic D, Stefanovic N, Ignjatovic A, Stojanovic I, et al. Oxidative and nitrosative stress in stable renal transplant recipients with respect to the immunosuppression protocol -differences or similarities? J Med Biochem [Internet]. 2015 [citado 21/12/2021];34(3):295-303. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922351/. https://dx.doi.org/10.2478/jomb-2014-0047
Kidokoro K, Satoh M, Nagasu H, Sakuta T, Kuwabara A, Yorimitsu D, et al. Tacrolimus induces glomerular injury via endothelial dysfunction caused by reactive oxygen species and inflammatory change. Kidney Blood Press Res [Internet]. 2012 [citado 21/12/2021];35(6):549-557. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22890154/. https://doi.org/10.1159/000339494
Vostálová J, Galandáková A, Rajnochová Svobodová A, Kajabová M, Schneiderka P, Zapletalová J. Stabilization of oxidative stress 1 year after kidney transplantation: effect of calcineurin immunosuppressives. Ren Fail [Internet]. 2012 [citado 21/12/2021];34(8):952-959. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22788842/. https://doi.org/10.3109/0886022x.2012.699874